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Abstract
Regulatory T (Treg) cells respond to immune and inflammatory signals to mediate 
immunosuppression, but how functional integrity of Treg cells is maintained under activating 
environments remains elusive. Here we found that autophagy was active in Treg cells and 
supported their lineage stability and survival fitness. Treg cell-specific deletion of the essential 
autophagy gene Atg7 or Atg5 led to loss of Treg cells, increased tumor resistance, and 
development of inflammatory disorders. Atg7-deficient Treg cells had increased apoptosis and 
readily lost Foxp3 expression, especially after activation. Mechanistically, autophagy deficiency 
upregulated mTORC1 and c-Myc function and glycolytic metabolism that contributed to defective 
Treg function. Therefore, autophagy couples environmental signals and metabolic homeostasis to 
protect lineage and survival integrity of Treg cells in activating contexts.
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Introduction
Regulatory T (Treg) cells play an indispensable role in preventing autoimmune disease and 
establishing self-tolerance1. The activation states and functional capacities of Treg cells are 
dynamically programmed by environmental signals2. Treg cells emerge from the thymus as 
quiescent central Treg cells (cTreg; CD44loCD62Lhi)3. In response to environmental cues in 
the periphery, a fraction of Treg cells are continuously activated and converted into effector 
Treg cells (eTreg; CD44hiCD62Llo) under steady state3,4. After an inflammatory challenge, 
Treg cells are further activated and potently upregulate their suppressive activity and 
contribute to the regulation of inflammatory responses induced by autoimmunity, tumor and 
other stimuli5. Thus, the activation states and functional capacities of Treg cells are 
dynamically programmed by environmental signals. As for cell-intrinsic pathways, 
continued expression of Foxp3 is required to reinforce Treg cell functional integrity
1
. While 
Foxp3 expression is stable in vivo6, Treg cells can lose Foxp3 expression and acquire effector 
function in certain inflammatory conditions7–10, suggesting that activating environments 
could destabilize Foxp3 expression. Aside from lineage stability, maintenance of the anti-
apoptotic program also contributes to the functional integrity of Treg cells in maintaining 
immune tolerance11.
Macroautophagy (herein referred to as autophagy) is an evolutionarily conserved self-
digestive process that targets intracellular substrates for lysosomal degradation and recycling 
in response to stress and other environmental signals12–14. Autophagy plays important and 
context-dependent roles in T cell-mediated immune responses. For example, autophagy is 
required for survival and TCR-induced proliferation of T cells15. In contrast, activated CD8+ 
cells deficient in autophagy exhibit normal proliferation and effector function, but with 
impaired memory cell formation16. Autophagy is induced after TCR and cytokine 
stimulation15,17,18, but virus-specific CD8+ T cells downregulate autophagy activity during 
clonal expansion, followed by induction of autophagy when they stop dividing16. These 
studies highlight dynamic and signal-dependent function and regulation of autophagy.
We report here that autophagy is actively regulated in Treg cells, and serves as a central 
signal-dependent controller of Treg cells by restraining excessive apoptotic and metabolic 
activities. We found that Treg cell-specific loss of the essential autophagy gene Atg7 or Atg5 
was sufficient to break self-tolerance while facilitating tumor clearance. Atg7-deficient Treg 
cells exhibited impaired lineage stability and increased apoptosis, thereby compromising 
their functional integrity. Although autophagy is known to promote energy balance14,17,19, 
we found that Treg cells deficient in autophagy showed increased mTORC1 activity, c-Myc 
expression and glycolytic metabolism, characteristic of anabolic upregulation20. Inhibition 
of mTORC1 or c-Myc in Atg7-deficient Treg cells partly restored Treg cell stability and 
metabolic homeostasis. Collectively, our studies establish a crucial role of autophagy in 
establishing Treg cell-mediated immune tolerance by coordinating immune signals and 
metabolic homeostasis to protect the functional integrity of Treg cells.
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RESULTS
Autophagy is functionally active in Treg cells
To investigate regulation of autophagy in Treg cells, we quantified autophagosomes in 
peripheral Treg cells and naïve CD4+ cells using transgenic mice expressing the green 
fluorescent protein (GFP) fused to LC3 (GFP-LC3), which labels autophagic membranes21. 
Treg cells had significantly more cells labeled with GFP-LC3+ puncta than did naïve CD4+ 
cells (Fig. 1a), suggesting increased autophagosomes in Treg cells. Lipidated LC3 (LC3-II) is 
another marker of autophagic membranes12–14; immunoblot analysis showed that Treg cells 
had higher amount of LC3-II than naïve CD4+ cells (Supplementary Fig. 1a). Treatment of 
cells with a lysosome inhibitor bafilomycin A1 (Baf1A), which blocks lysosome-mediated 
degradation of autophagosomes, increased the amount of LC3-II in both Treg cells and naïve 
CD4+ cells, but Treg cells still had higher amount of LC3-II than naïve CD4+ cells 
(Supplementary Fig. 1a). Therefore, Treg cells have higher autophagy activity than naïve 
CD4+ cells, indicating a possible role of autophagy in Treg cells.
To test this hypothesis, we crossed mice with loxP-flanked Atg7 alleles (Atg7fl/fl) with 
Foxp3YFP-Cre (Foxp3Cre) mice to delete the essential autophagy gene Atg7 in Treg cells 
(hereafter Foxp3CreAtg7fl/fl). Deletion of Atg7 abrogated autophagy in Treg cells, as 
indicated by the absence of LC3-II in immunoblot analysis (Supplementary Fig. 1a). To 
determine whether Treg cells require autophagy to suppress antitumor immune responses, we 
inoculated Foxp3CreAtg7fl/fl mice with MC38 colon adenocarcinoma cells. Tumor growth 
was severely inhibited in Foxp3CreAtg7fl/fl mice, suggesting that Atg7-deficient Treg cells 
failed to inhibit antitumor immune response (Fig. 1b). Consistent with this notion, 
Foxp3CreAtg7fl/fl mice had greatly increased percentage of tumor-infiltrating CD8+ cells 
(Supplementary Fig. 1b), and expression of interferon-γ (IFN-γ) in effector CD4+ and CD8+ 
T cells (Fig. 1c). However, Foxp3CreAtg7fl/fl mice had a profound loss of Treg cells in the 
tumor site (Fig. 1d). These results identify a crucial role of Atg7 in endowing Treg cells the 
ability to suppress antitumor immune responses.
Treg deletion of Atg7 or Atg5 alters immune homeostasis
The indispensable role of Atg7 in maintaining Treg cells in a pathological condition 
prompted us to determine the requirement of autophagy in Treg cells in maintaining self-
tolerance under homeostatic conditions. Foxp3CreAtg7fl/fl mice at 10–12 weeks of age 
developed lymphoid hyperplasia with increased cellularity of the spleen and peripheral 
lymph nodes (PLNs) (Fig. 1e, Supplementary Fig. 1c). Foxp3CreAtg7fl/fl mice contained a 
higher proportion of the effector or memory population (CD44hiCD62Llo) in the CD4+ and 
CD8+ compartments (Fig. 1f). Moreover, CD44hi cells from Foxp3CreAtg7fl/fl mice showed 
increased expression of IFN-γ and interleukin 17 (IL-17) (Fig. 1g), but not IL-4 
(Supplementary Fig. 1d). Therefore, T cells from Foxp3CreAtg7fl/fl mice were spontaneously 
activated in vivo. Moreover, severe systemic inflammatory disorders were observed in aged 
Foxp3CreAtg7fl/fl mice (19–23 weeks old) with infiltrations of lymphocytes and myeloid 
cells observed in various organs (Fig. 1h). Thus, Atg7 is essential for Treg cell-mediated 
immune homeostasis.
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As autoimmune disease is frequently associated with loss of Treg cells, we examined Treg 
cells in the lymphoid organs of Foxp3CreAtg7fl/fl mice. Treg cell percentages were 
significantly reduced in spleen, PLNs and mesenteric lymph nodes (MLNs), but not the 
thymus, although Treg cell numbers remained largely unaltered due to the increase of total T 
cells (Fig. 1i). A more severe reduction of Treg cells was observed in colon lamina propria, a 
representative site of Treg activation, even in very young Foxp3CreAtg7fl/fl mice 
(Supplementary Fig. 1e). We next investigated whether Treg cell reduction in 
Foxp3CreAtg7fl/fl mice was a cell-autonomous defect. We generated mixed bone marrow 
(BM) chimeras by reconstituting Rag1−/− mice with BM cells from CD45.1+ mice mixed 1:1 
with those from either Foxp3CreAtg7+/fl or Foxp3CreAtg7fl/fl CD45.2+ mice. Atg7-deficient 
Treg cells were underrepresented in the spleen, PLNs and MLNs, but not the thymus 
(Supplementary Fig. 1f), indicative of a cell-autonomous requirement of Atg7 in Treg cell 
maintenance.
To conclusively test the role of autophagy in Treg cells, we deleted another essential 
autophagy gene, Atg5, in Treg cells by crossing Atg5fl/fl mice with Foxp3YFP-Cre mice 
(Foxp3CreAtg5fl/fl). Foxp3CreAtg5fl/fl mice had disrupted immune homeostasis of CD4+ and 
CD8+ cells (Supplementary Fig. 1g), associated with increased IFN-γ expression 
(Supplementary Fig. 1h). Additionally, Foxp3CreAtg5fl/fl mice had reduced Treg cell 
percentage (Supplementary Fig. 1i). Therefore, these results establish autophagy as a central 
and intrinsic regulator of Treg cell maintenance and immune homeostasis.
Impaired survival and stability of Atg7-null Treg cells
To investigate the underlying basis for the reduced cellularity of Atg7-deficient Treg cells, 
we first examined Treg cell proliferation. Treg cells in Foxp3CreAtg7fl/fl mice actually 
contained a higher percentage of Ki67+ cells than those in Foxp3CreAtg7+/fl mice 
(Supplementary Fig. 2a), but Atg7-deficient Treg cells from the mixed BM chimeras had 
normal percentage of Ki67+ cells (Supplementary Fig. 2b). Moreover, Foxp3CreAtg7+/fl and 
Foxp3CreAtg7fl/fl Treg cells showed comparable proliferation after in vitro stimulation or 
adoptive transfer into Rag1−/− mice (Supplementary Fig. 2c,d). Thus, Atg7 is dispensable for 
Treg cell proliferation, and the reduced Treg cellularity in the absence of Atg7 is unlikely to 
result from a proliferative defect.
Because peripheral Treg cell number is tightly regulated by apoptosis
11
, we next examined 
apoptosis of Treg cells. Treg cells in Foxp3CreAtg7fl/fl mice had greatly increased staining of 
active caspase-3 as compared to those in Foxp3CreAtg7+/fl mice (Fig. 2a), indicative of a 
higher rate of apoptosis. Additionally, upon in vitro stimulation, Atg7-deficient Treg cells 
were impaired in survival, as indicated by the increased staining with active caspase-3 and 7-
AAD (Fig. 2b), and upregulation of Bim, which initiates Treg apoptosis11 (Fig. 2c). Atg7-
deficient Treg cells from mixed BM chimeras also had increased active caspase-3 and Bim 
expression (Supplementary Fig. 2e,f), indicative of a cell-autonomous requirement of Atg7 
in Treg cell survival.
Aside from cell survival, lineage stability of Treg cells is crucial for their maintenance and 
function7–10. Although mean fluorescence intensity (MFI) of Foxp3 was comparable in 
Atg7-sufficient and deficient Treg cells (data not shown), Treg cells from Foxp3CreAtg7fl/fl 
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mice had significantly elevated expression of IFN-γ under steady state (Fig. 2d), and upon 
tumor inoculation (Supplementary Fig. 2g). To directly examine the role of autophagy in 
maintaining Foxp3 expression in activated Treg cells in vivo, we transferred Atg7-sufficient 
and deficient Treg cells into Rag1−/− mice and assessed Foxp3 expression at 7–10 days after 
transfer. While only a small proportion of Atg7-sufficient Treg cells lost Foxp3 expression 
following homeostatic proliferation, the majority of Atg7-deficient Treg cells were unable to 
maintain Foxp3 (Fig. 2e). Loss of Foxp3 expression in Atg7-deficient Treg cells was 
associated with acquisition of production of IFN-γ, and to a lesser extent, IL-17 (Fig. 2f). 
IFN-γ expression was also elevated in the residual Foxp3+ Treg cells deficient in Atg7 (Fig. 
2f). Moreover, in an in vitro system to measure stability of activated Treg cells22,23, Atg7-
deficient Treg cells had greatly reduced Foxp3 (Fig. 2g) and elevated IFN-γ expression 
(Supplementary Fig. 2h). Collectively, Treg cells lacking Atg7 show impaired Foxp3 
expression but aberrant acquisition of inflammatory cytokine expression in vivo and in vitro, 
indicating a central role of autophagy in maintaining the stability of Treg cells.
To explore the relationship between survival and stability defects of Atg7-deficient Treg 
cells, we crossed Foxp3CreAtg7fl/fl mice with mice expressing a Bcl2 transgene in 
lymphocytes (Bcl2-transgenic, Bcl2-TG)24. The excessive apoptosis of Foxp3CreAtg7fl/fl 
Treg cells was reduced in Foxp3CreAtg7fl/flBcl2-TG cells (Supplementary Fig. 2i). However, 
Foxp3CreAtg7fl/flBcl2-TG mice still had reduced Treg cell percentage and spontaneously 
activated conventional T cells (Supplementary Fig. 2j,k). Additionally, as compared with 
Treg cells from control Bcl2-TG mice, those from Foxp3CreAtg7fl/flBcl2-TG mice had 
elevated expression of IFN-γ (Supplementary Fig. 2l), and reduced Foxp3 expression after in 
vitro culture (Supplementary Fig. 2m). Therefore, survival and stability defects of Atg7-
deficient Treg cells represent two discrete effects induced by loss of autophagy.
Atg7 restricts TCR-dependent mTORC1 signaling
To explore the biochemical basis for Atg7 functions, we performed functional genomics 
studies and found that phosphatidylinositol-3-OH kinase (PI(3)K) p110δ signaling, which 
was crucial for mTORC1 activation, was enhanced in Foxp3CreAtg7fl/fl Treg cells (data not 
shown). Further, Foxp3CreAtg7fl/fl Treg cells had increased cell size and CD71 and CD98 
expression (Fig. 3a), all of which are dependent upon mTORC1 signaling25. Indeed, flow 
cytometry analysis showed that Treg cells from Foxp3CreAtg7fl/fl mice had increased S6 
phosphorylation, indicative of mTORC1 activation (Fig. 3a). After anti-CD3 and anti-CD28 
stimulation, Atg7-deficient cells exhibited a more pronounced upregulation of S6 and 
4EBP1phosphorylation, as compared with Atg7-sufficient Treg cells (Fig. 3b). Furthermore, 
Atg5-deficient Treg cells had increased cell size, CD71 and CD98 expression, and S6 
phosphorylation (Supplementary Fig. 3a). Therefore, autophagy is essential for restraining 
mTORC1 activity in Treg cells.
Signals from TCR, CD28 co-stimulation and IL-2 elicit mTORC1 activity26. To investigate 
the involvements of upstream inputs for mTORC1 regulation, we activated Treg cells with 
different stimuli and measured S6 phosphorylation. Anti-CD3 stimulation resulted in 
hyperactivation of S6 phosphorylation in Foxp3CreAtg7fl/fl Treg cells, and CD28 co-
stimulation further boosted S6 phosphorylation in both Foxp3CreAtg7+/fl and 
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Foxp3CreAtg7fl/fl Treg cells (Fig. 3c). The kinases PI(3)K, Akt and PDK1 are known to 
contribute to mTORC1 activation in response to TCR-CD28 stimulation26. To determine the 
molecular basis for TCR-CD28-induced aberrant mTORC1 activation in the absence of 
Atg7, we treated cells with inhibitors for PI(3)K (LY294002), Akt (AKTi-1/2), and PDK1 
(PDKi). Inhibition of PI(3)K and PDK1, but not Akt, blocked excessive S6 phosphorylation 
in Atg7-deficient Treg cells (Fig. 3d). Moreover, compared with control cells, Atg7-deficient 
Treg cells had moderately increased expression of the PI(3)K components p110δ and p85, 
and PDK1 (Supplementary Fig. 3b), while expression of Lck or phosphorylation of total 
tyrosine residues including Lck was unaltered (Supplementary Fig. 3b and data not shown). 
These results indicate that autophagy negatively regulates PI(3)K-PDK1 abundance and 
activation.
To determine the contribution of aberrant mTORC1 signaling to the defects in Atg7-
deficient Treg cells, we treated Foxp3CreAtg7fl/fl mice with rapamycin in vivo. Rapamycin 
treatment moderately reduced active capase-3 staining (Fig. 3e), but more importantly, 
greatly diminished IFN-γ production in Treg cells in Foxp3CreAtg7fl/fl mice (Fig. 3f). 
Moreover, following adoptive transfer of Atg7-sufficient and deficient Treg cells into 
Rag1−/− mice, treatment of recipients with rapamycin largely restored Foxp3 expression in 
donor-derived Atg7-deficient Treg cells (Fig. 3g). Rapamycin also rectified Foxp3 expression 
in Atg7-deficient Treg cells in the in vitro Treg cell stability assay (Fig. 3h). Therefore, 
autophagy maintains Treg cell stability, at least in part, by restraining mTORC1 signaling.
Atg7-mediated transcriptional programs rely on mTORC1
To explore autophagy-dependent transcriptional programs, we analyzed gene expression 
profiles of in vitro activated Treg cells. Compared to Foxp3CreAtg7+/fl cells, expression of 
360 and 398 probes were respectively upregulated and downregulated (by greater than 0.5 
log2 fold change) in Foxp3CreAtg7fl/fl Treg cells (Fig. 4a). To identify key networks regulated 
by autophagy in activated Treg cells, we did gene-set enrichment analysis (GSEA)27. 
Consistent with our finding that Atg7-deficient Treg cells had defective survival and stability, 
the caspase and cytokine pathways were enriched in these cells (Fig. 4b,c). Furthermore, T 
helper cell differentiation pathway was identified to be the most enriched canonical pathway 
in Atg7-deficient Treg cells by ingenuity pathway analysis (IPA) of the differentially 
expressed genes at the 0.5 log2 cut-offs (Supplementary Fig. 4a). Also, IPA of upstream 
regulation revealed the activation of PI(3)K in Atg7-deficient Treg cells, but suppression of 
Foxp3, Foxo3 and Bach2 – factors crucial for Treg cell generation and maintenance by 
repressing effector programs1,28,29 (Supplementary Fig. 4b). Therefore, these functional 
genomics analyses support a crucial role of Atg7 in restraining cytokine expression and 
effector programs in Treg cells.
To determine the contribution of aberrant mTORC1 to Atg7-mediated transcriptional 
programs, we compared gene expression profiles of in vitro activated Treg cells from 
Foxp3CreAtg7+/fl and Foxp3CreAtg7fl/fl mice with or without rapamycin treatment. Atg7-
dependent targets (a total of 758 probes) were partitioned into five distinct clusters that 
differed in their responses to rapamycin (Fig. 4d). A salient feature was that the majority of 
Atg7 targets (493 out of 758 probes) fell into cluster 1, in which their expression was 
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rectified by rapamycin. Moreover, cluster 5 contained 13 probes whose expression was 
partially rectified by rapamycin, and cluster 2 contained 9 probes that showed the opposite 
direction of change in expression. Thus, ~68% (clusters 1, 2 and 5) of all Atg7 targets were 
rapamycin responsive as they had a diminished response after rapamycin treatment (Fig. 
4d,e). In contrast, only 217 probes in cluster 4 had equal magnitude of change (> 0.5 log2 
fold change) in both rapamycin-treated and non-treated Foxp3CreAtg7fl/fl Treg cells, thus 
representing rapamycin non-responsive genes. In addition, cluster 3 contained 26 probes that 
were differentially expressed in both types of comparisons, but to a greater extent in 
rapamycin-treated Foxp3CreAtg7fl/fl Treg cells compared with non-treated Foxp3CreAtg7fl/fl 
cells. Furthermore, rapamycin considerably rectified expression of genes associated with 
gene sets altered by Atg7 deficiency described above, namely caspase and cytokine 
pathways (Supplementary Fig. 4c,d). These results identify a crucial contribution of 
mTORC1 to autophagy-dependent transcriptional programs.
Atg7 restraints glycolytic metabolism in Treg cells
Differentiation of Treg cells is shaped by metabolic programs
30
–
32
, but how Treg stability is 
controlled by cellular metabolism remains unclear. The aberrant activation of mTORC1 in 
Atg7-deficient Treg cells prompted us to examine the involvement of metabolic programs. 
We measured mitochondrial oxygen consumption rate (OCR) and extracellular acidification 
rate (ECAR), which denote mitochondrial OXPHOS and glycolytic activities, respectively. 
After TCR-CD28 stimulation, Foxp3CreAtg7+/fl and Foxp3CreAtg7fl/fl Treg cells had 
comparable OCR (Supplementary Fig. 5a), but ECAR was significantly elevated in 
Foxp3CreAtg7fl/fl Treg cells (Fig. 5a). The reduced OCR/ECAR ratio in Atg7-deficient Treg 
cells indicated a preferential use of glycolysis over OXPHOS by these cells (Fig. 5b). 
Moreover, rapamycin treatment reduced ECAR in Atg7-deficient Treg cells (Fig. 5c), 
indicating a crucial role of mTORC1 in Atg7-dependent metabolic homeostasis.
To examine the functional importance of cellular metabolism, we treated Atg7-deficient 
cells with dichloroacetate (DCA) in the Treg stability assay; DCA shifts glycolysis towards 
OXPHOS by targeting pyruvate dehydrogenase kinase30. DCA treatment elevated Foxp3 
expression in Foxp3CreAtg7+/fl and Foxp3CreAtg7fl/fl Treg cells to a largely comparable level 
(Fig. 5d). Of note, methylation of Treg cell-specific demethylated region (TSDR, also known 
as CNS2) is associated with maintenance of Foxp3 expression and Treg cell stability23,33. 
TSDR methylation was comparable between Atg7-sufficient and deficient Treg cells, and 
DCA treatment had no effect (Supplementary Fig. 5b). Thus, autophagy-dependent 
metabolic regulation contributes to Foxp3 expression but in a process independent of TSDR 
methylation.
To determine molecular basis for the altered glycolysis, we examined expression of 
hexokinase 2 (HK2), a rate-limiting enzyme in glycolysis. HK2 expression was increased in 
Foxp3CreAtg7fl/fl Treg cells (Supplementary Fig. 5c), but was considerably reduced by 
rapamycin treatment (Supplementary Fig. 5d). In contrast, although the mTORC1-HIF1α 
pathway promotes glycolysis in TH17 cells and effector CD8+ T cells
32
,
34
, HIF1α 
expression was not altered in Atg7-deficient Treg cells (Supplementary Fig. 5e,f). Altogether, 
Atg7 negatively controls mTORC1-dependent glycolytic metabolism in Treg cells.
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c-Myc links mTORC1 to glycolysis of Treg cells
Aside from HIF1α, c-Myc is another crucial regulator of T cell glycolysis35. c-Myc pathway 
was enriched in our IPA analysis of Atg7-deficient Treg cells (data not shown). Compared 
with Treg cells from Foxp3CreAtg7+/fl mice, those from Foxp3CreAtg7fl/fl Treg mice had 
increased c-Myc expression following anti-CD3-CD28 stimulation (Fig. 6a,b). To determine 
if upregulation of c-Myc in Atg7-deficient Treg cells depends upon mTORC1, we treated 
Foxp3CreAtg7fl/fl mice with rapamycin and examined c-Myc expression in Treg cells. 
Rapamycin treatment considerably reduced c-Myc expression in Atg7-deficient Treg cells 
(Fig. 6c). Moreover, dysregulated expression of c-Myc-associated genes in Atg7-deficient 
Treg cells was rectified upon rapamycin treatment (Fig. 6d). To further explore the role of 
mTORC1 in mediating c-Myc expression in Atg7-deficient Treg cells, we crossed 
Cd4CreAtg7fl/fl mice with Rptorfl/fl mice to abolish Raptor, the essential component of 
mTORC1, in Atg7-deficient T cells. Raptor deletion strongly reduced c-Myc expression in 
Atg7-deficient Treg cells (Supplementary Fig. 6a). These results indicate that Atg7 regulates 
c-Myc expression in Treg cells in an mTORC1-dependent manner.
The Myc locus is enriched with binding sites for bromodomain-containing proteins that 
recognize acetylated lysine residues of histones36, and two bromodomain inhibitors, JQ-1 
and i-BET-762, effectively inhibit c-Myc expression and function36,37 (data not shown). To 
determine the contribution of aberrant c-Myc expression to increased glycolysis in 
Foxp3CreAtg7fl/fl Treg cells, we treated cells with JQ-1 and measured ECAR. JQ-1 treatment 
reduced ECAR in Atg7-deficient Treg cells (Fig. 6e). In the in vitro Treg stability assay, JQ-1 
or i-BET-762 restored Foxp3 expression in Atg7-deficient Treg cells (Fig. 6f and 
Supplementary Fig. 6b). Therefore, Atg7 maintains Treg cell stability by targeting mTORC1-
c-Myc pathway.
Activated Treg cells are sensitive to Atg7 deficiency
Under steady state, Treg cells are spontaneously and continuously activated in response to 
self-antigens and environmental cues3,4. To explore the role of autophagy in Treg cells with 
different activation states, we crossed Foxp3CreAtg7fl/fl mice with mice transgenic for GFP 
driven by the recombination-activating gene 2 (Rag2) promoter to label recent thymic 
emigrates (RTEs) with GFP38. In these mice, GFP+ peripheral T cells represent RTEs that 
have left the thymus within 2–3 weeks and show naïve phenotypes, while GFP− cells are 
mature peripheral T cells that have experienced peripheral environment cues3,38. Treg cells in 
Rag2GFPFoxp3CreAtg7fl/fl mice were diminished in the GFP− compartment, but not in the 
GFP+ compartment, as compared with the counterparts in Rag2GFPFoxp3CreAtg7+/fl mice 
(Fig. 7a). Additionally, the increased apoptosis of Atg7-deficient Treg cells, as determined by 
active caspase-3 staining, was observed only in the GFP− compartment (Fig. 7b). These 
results identify a preferential requirement of autophagy in maintaining the cellularity and 
survival of activated Treg cells.
Published reports highlight that the activated eTreg cells differentiate from the quiescent 
cTreg population in response to environmental cues
3
,
4
. Autophagy activity was upregulated 
in eTreg cells, as revealed by the significantly more GFP-LC3+ puncta in eTreg than cTreg 
cells (Fig. 7c). In Foxp3CreAtg7fl/fl mice, the eTreg population was modestly 
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underrepresented in Treg cells (Fig. 7d), but such defect was more pronounced in a 
competitive environment created by the mixed BM chimeras (Fig. 7e), indicating a cell-
autonomous requirement of Atg7 in this process. Moreover, eTreg cells in Foxp3CreAtg7fl/fl 
mice showed a more pronounced upregulation of apoptosis compared with cTreg cells (Fig. 
7f). In line with this, eTreg cells had higher basal level of mTORC1 activity than cTreg cells 
as determined by S6 phosphorylation, and Atg7 deficiency augmented mTORC1 activity to 
a greater degree in eTreg cells (Fig. 7g). Thus, autophagy functions in both Treg subsets, but 
eTreg cells are more sensitive to autophagy deficiency, in agreement with their more 
activated state and elevated mTORC1 activity (Supplementary Fig. 7).
Discussion
A salient feature of the autoreactive Treg cells is the dynamic programming of their 
activation states in response to environmental and immune signals. How Treg cells maintain 
their survival fitness and lineage stability under the activating environments is poorly 
understood. Here we identify that autophagy is dynamically regulated in Treg cells, and 
deletion of Atg7 or Atg5 specifically in Treg cells results in increased apoptosis and impaired 
lineage stability. We further reveal an inhibitory effect of autophagy on mTORC1 that 
contributes to the survival and stability of Treg cells. Furthermore, aberrant mTORC1 
elevates c-Myc expression and glycolytic metabolism in autophagy-deficient Treg cells, and 
pharmacological blocking of excessive mTORC1, c-Myc or glycolytic activities restores, at 
least in part, the impaired stability of autophagy-deficient Treg cells. Our studies therefore 
establish autophagy as a crucial regulator of Treg functional integrity, and identify a key role 
of autophagy in restraining mTORC1 and c-Myc function and glycolytic metabolism.
Homeostatic stimuli and environmental cues drive the continuous activation and progressive 
functional maturation of Treg cells
2
. However, after activation in vivo and in vitro, a 
proportion of Treg cells lose Foxp3 expression and lineage stability
22
,
23
. One unanswered 
question is therefore how Treg cells retain their survival fitness and functional integrity in 
activating contexts. Our studies identify an important role of autophagy in this process. Treg 
cells exhibit higher autophagy activity than naïve T cells, and they further upregulate 
autophagy in the activated eTreg subset. The exact stimuli that induce autophagy in Treg cells 
remain to be identified. Autophagy deficiency has a more pronounced effect on the 
maintenance of activated Treg cells than resting Treg cells in the periphery under steady state, 
and at sites of inflammation including tumor microenvironment and colon lamina propria. 
Moreover, Atg7-deficient Treg cells readily lose Foxp3 expression after extensive 
proliferation in Rag1−/− mice, or after TCR stimulation in vitro. These results identify a 
previously unappreciated mechanism that functions preferentially in activated Treg cells to 
protect their survival fitness and lineage stability.
mTORC1 signaling is widely recognized as a negative regulator of autophagy. Specifically, 
in a nutrient-replete environment, activation of mTORC1 inhibits autophagy; 
downregulation of mTORC1 activity under nutrient deprivation facilitates the induction of 
autophagy12–14. However, prolonged starvation can result in the reactivation of mTORC1 in 
an autophagy-dependent manner by degradation of autolysosomal products39. Unexpectedly, 
we found that autophagy plays an important role in restricting mTORC1 activation in Treg 
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cells activated by TCR and other stimuli. Of note, mTORC1 is a crucial regulator in Treg 
cells, and either diminished or excessive mTORC1 disrupts Treg cell suppressive 
functions40,41. The in vivo rapamycin treatment experiment highlights the impacts of 
mTORC1 dysregulation on the stability and survival of Treg cells, and transcriptional 
programs controlled by Atg7. As for the biochemical mechanism by which autophagy 
regulates mTORC1 signaling, one possibility is that autophagy targets selective TCR 
signaling components or mTORC1 upstream regulators for degradation to modulate the 
strength of mTORC1 signaling. For example, a recent study indicates that autophagy shapes 
how TCR signals to NF-κB in effector T cells by selective degradation of Bcl-10, although 
the underlying mechanisms and functional outcomes are context-dependent42. In support of 
this notion, protein abundance of PI(3)K components and PDK1 are increased in the absence 
of autophagy, and pharmacological inhibition of PI(3)K or PDK1 blocks mTORC1 
hyperactivation in Atg7-deficient Treg cells. Future studies are warranted to reveal the 
detailed biochemical pathway by which autophagy modulates the activity of PI(3)K and 
PDK1 signaling.
T cell survival, proliferation and function require dynamic reprogramming of cellular 
metabolism20, and glycolytic capacity and reserve are severely impaired in the in vitro 
generated Treg cells compared with TH1 and TH17 cells
30
. How glycolytic activity is 
restrained in Treg cells remains poorly defined, and our results identify a crucial inhibitory 
effect of autophagy on Treg cell glycolysis. Importantly, pharmacological blocking of 
glycolytic metabolism or c-Myc function partly restores the defective stability of Atg7-
deficient Treg cells, thereby highlighting the functional contribution of dysregulated 
metabolism in this process. We and others have recently described a role of the phosphatase 
PTEN in the regulation of T cell glycolysis in Treg cells
43
,
44
. However, PTEN mainly 
restricts mTORC2 but not mTORC1 activity in Treg cells, and acts to control TH1 and TFH 
cell responses43,44. In contrast, Atg7-deficient Treg cells show dysregulated mTORC1-c-Myc 
signaling and are selectively defective in controlling TH1 cell response, without affecting 
TFH cell responses (our unpublished observation), suggesting that Treg cells employ discrete 
mechanisms to properly establish their metabolic programs. Interestingly, whereas our study 
indicates a negative role of glycolysis in the maintenance of Treg cell stability, a recent study 
identifies that induction of Treg cells from human conventional T cells is dependent on 
glycolysis45, thereby highlighting context-dependent functions of glycolysis in Treg cell 
biology.
In summary, our study has unveiled the interplay between autophagy and metabolic 
programming as a new mechanism to enforce Treg cell functional integrity in response to 
immune signals. We further establish that autophagy acts as a negative regulator of 
mTORC1 and c-Myc function and glycolytic metabolism to maintain metabolic balance in 
activated Treg cells. The identification of autophagy as a central signal-dependent quality 
control mechanism in Treg cells provides new opportunities for therapeutic intervention of 
autoimmune diseases and cancer. From this perspective, by strengthening tumor-associated 
immune responses, targeting Treg cell autophagy could act in synergy with strategies that 
block autophagy in tumor cells for added benefits in cancer therapy13.
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Online methods
Mice
Rag1−/− and Rag2GFP mice38 were purchased from the Jackson Laboratory. GFP-LC3, 
Atg7fl/fl and Atg5fl/fl mice were as described21,46,47. Foxp3YFP-Cre mice were a gift from A. 
Rudensky48. Foxp3CreAtg7fl/fl mice were used at 7–16 weeks old unless otherwise noted, 
with the age and gender-matched Foxp3CreAtg7+/fl mice as controls. For treatment with 
rapamycin, mice were injected intraperitoneally with rapamycin (4 mg per kg body weight) 
daily, and then analyzed five days later. BM chimeras were generated by transferring 5 × 106 
T cell-depleted BM cells into sublethally irradiated (5 Gy) Rag1−/− mice. All mice were kept 
in a specific pathogen-free facility in the Animal Resource Center at St. Jude Children’s 
Research Hospital. Animal protocols were approved by the Institutional Animal Care and 
Use Committee of St. Jude Children’s Research Hospital.
Flow cytometry
For analysis of surface markers, cells were stained in PBS containing 2% (wt/vol) BSA, with 
anti-CD4 (RM4-5), anti-CD8α (53-6.7), anti-TCRβ (H57-597), anti-CD44 (1M7), anti-
CD62L (MEL-14), anti-CD45.1 (A20), anti-CD45.2 (104), anti-CD71 (R17217), and anti-
CD98 (RL388; all from eBioscience). Intracellular Foxp3 (FJK-16s), Ki67 (SolA15), IFN-γ 
(XMG1.2), IL-4 (11B11), IL-17 (17B7; all from eBioscience), Bim (C34C5), c-Myc 
(D84C12), and p-S6 (D57.2.2E; all from Cell Signaling Technology) were analyzed by flow 
cytometry according to the manufacturer’s instructions. For intracellular cytokine staining, T 
cells were stimulated for 4 h with PMA plus ionomycin in the presence of monensin before 
intracellular staining according to the manufacturer’s instructions (eBioscience). Caspase-3 
activity was measured using active caspase-3 apoptosis kit (BD Biosciences). To monitor 
cell division, lymphocytes were labeled with CellTrace™ violet (Life Technologies). Flow 
cytometry data were acquired on LSRII or LSR Fortessa (BD Biosciences) and analyzed 
using Flowjo software (Tree Star).
Imaging and histology
Purified GFP-LC3 naïve CD4+ cells and Treg cells were rested in complete medium for 1 h 
at 37°C. Cells were harvested and fixed by 4% (vol/vol) neutral buffered paraformaldehyde 
solution. Images were acquired using a Zeiss Axio ObserverZ.1 microscope equipped with a 
CSU-22 spinning disk (Yokagawa), Delta Evole EMCCD camera (Photometrics), 100× 1.45 
NA oil objective and Slidebook imaging software (3i Intelligent Imaging Innovations). 
Images were subsequently processed using a Laplacian filter to detect GFP-LC3+ punctum 
objects having a minimum volume of 0.1 μm3. Frequency of cells with GFP-LC3+ puncta 
and number of GFP-LC3+ puncta per cell were determined for each sample. For histology 
analysis, tissues were fixed by 10% (vol/vol) neutral buffered formalin solution, embedded 
in paraffin, sectioned and stained with hematoxylin and eosin, and the clinical signs of 
autoimmune diseases were analyzed by an experienced pathologist (P. Vogel).
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Tumor model
MC38 colon adenocarcinoma cells were maintained in our laboratory and cultured in 
DMEM medium supplemented with 10% (vol/vol) FBS and 1% (vol/vol) penicillin-
streptomycin. Gender-matched Foxp3CreAtg7+/fl mice and Foxp3CreAtg7fl/fl mice were 
injected subcutaneously with 2 × 105 MC38 colon adenocarcinoma cells in the right flank. 
Tumors were measured regularly with digital calipers and tumor volumes were calculated by 
the formula: Length × Width × [(Length × Width) ^ 0.5] × π/6. To prepare tumor infiltrating 
lymphocytes (TILs), tumor was excised, minced and digested with 0.5 mg/ml Collagenase 
IV (Roche) + 200 U/ml DNase I (Sigma) for 1 h at 37°C. TILs were isolated by density-
gradient centrifugation over Percoll (Life Technologies).
Cell purification and culture
Unless otherwise noted, lymphocytes were isolated from spleen and PLNs, that included 
inguinal, auxiliary and cervical lymph nodes, and naïve CD4+ cells (CD4+Foxp3-
YFP−CD44loCD62Lhi), Treg cells (CD4+Foxp3-YFP+), cTreg cells (CD4+Foxp3-
YFP+CD44loCD62Lhi) and eTreg cells (CD4+Foxp3-YFP+CD44hiCD62Llo) were sorted on 
a MoFlow (Beckman-Coulter) or Reflection (i-Cyt). Sorted Treg cells were cultured in plates 
coated with anti-CD3 (145-2C11) and anti-CD28 (37.51; both from eBioscience) for 4 days 
in Click’s medium supplemented with β-mercaptoethanl, 10% (vol/vol) FBS, 1% (vol/vol) 
penicillin-streptomycin and 200 U/ml IL-2. In some experiments, rapamycin (50 nM), JQ-1 
(500 nM), i-BET-762 (500 nM) and DCA (10 mM) were added to the culture.
Adoptive transfer
For adoptive transfer, Treg cells from Foxp3CreAtg7+/fl mice and Foxp3CreAtg7fl/fl mice 
were transferred to the Rag1−/− mice. Seven to ten days after the transfer, recipients were 
euthanized for the analysis of Foxp3 and cytokine expression in transferred cells. For 
treatment with rapamycin, Rag1−/− mice were injected intraperitoneally with rapamycin (2 
mg per kg body weight) every other day from day 1, and then analyzed at day 10.
RNA and Immunoblot analysis
Real-time PCR analysis was performed with primers and probe sets from Applied 
Biosystems, as described49. Immunoblots were performed as described previously24, using 
the following antibodies: Lck (2752), HK2 (C64G5), p85 (19H8), PDK1 (3062), p-S6 (2F9), 
p-4EBP1 (236B4), c-Myc (D84C12; all from Cell Signaling Technology), LC3 
(NB100-2220; Novus), p110δ (EPR386; Abcam), HIF1α (10006421; Cayman) and β-actin 
(AC-15; Sigma).
Seahorse assays
Sorted Treg cells were stimulated with plate-bound anti-CD3 and anti-CD28 for 4 h in the 
presence of IL-2. In certain experiments, rapamycin (50 nM) and JQ-1 (500 nM) were added 
to the culture. After stimulation, cells were re-plated in XF media (non-buffered DMEM 
containing 5 mM glucose, 2 mM L-glutamine and 1 mM sodium pyruvate). XF-24 
Extracellular Flux Analyzer (Seahorse Bioscience) was used to measure OCR and ECAR in 
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response to 1 μM oligomycin, 2 μM fluoro-carbonyl cyanide phenylhydrazone (FCCP) and 1 
μM Rotenone.
Methylation analysis of Treg cell-specific demethylated region
CellTrace-labeled Treg cells were cultured with anti-CD3, anti-CD28, and IL-2 for 4 days in 
the presence of DMSO or DCA. Divided cells were sorted, and genomic DNA was prepared 
by a DNeasy Blood & Tissue kit (Qiagen). Bisulfite conversion of DNA was conducted with 
an EZ DNA Methylation-Direct kit (Zymo Research). Intron 1 of Foxp3 (corresponding to 
CNS2) was amplified with a primer set as described (forward, 5′-
TATTTTTTTGGGTTTTGGGATATTA-3′ and reverse, 5′-
AACCAACCAACTTCCTACACTATCTAT-3′)44. PCR products were ligated into pGEM-T 
Easay vectors (Promega) and sequenced (more than 29 sequences per sample).
Gene expression profiling and bioinformatic analysis
Treg cells from Foxp3CreAtg7+/fl mice (n=4), Foxp3CreAtg7fl/fl mice (n=4), rapamycin-
treated Foxp3CreAtg7+/fl mice (n=4) and rapamycin-treated Foxp3CreAtg7fl/fl mice (n=4) 
were stimulated with plate-bound anti-CD3 and anti-CD28 for 4 h. RNA samples from these 
cells were analyzed with the Mouse Gene 2.0 ST Signals array. Differentially expressed 
transcripts were identified by ANOVA (Partek Genomics Suite v6.5) and the Benjamini-
Hochberg method was used to estimate the false discovery rate (FDR) as described 
previously25. Lists of differentially expressed genes at the 0.5 log2 cut-offs were used for 
IPA canonical pathway and upstream signaling analyses. GSEA was performed as 
described27. The microarray data have been deposited into the GEO series database 
(GSE75218).
Statistical analysis
Prism 5 software (GraphPad) was used to analyze data by performing two-tail unpaired 
Student’s t-test. When multiple groups were compared, one-way ANOVA with the Tukey 
test was performed. P value of less than 0.05 was considered significant. All error bars 
represent the s.e.m.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Treg cells have active autophagy and require Atg7 for mediating tumor immune 
tolerance and self-tolerance
(a) Representative images (scale bars, 5 μm) (left) and quantification of percentages of cells 
with GFP-LC3+ puncta (right) in peripheral naïve CD4+ cells and Treg cells purified from 
GFP-LC3 mice (n=3 mice). (b–d) Foxp3CreAtg7+/fl and Foxp3CreAtg7fl/fl mice (n=4 mice 
per genotype) were inoculated with MC38 colon adenocarcinoma cells, and tumor growth 
(b) was measured. Flow cytometry analyzing IFN-γ expression in Foxp3−CD4+ and CD8+ T 
cells (c, left), frequency of IFN-γ+ cells (c, right) and Foxp3 expression in CD4+ T cells (d) 
in tumor-infiltrating lymphocytes. Numbers in quadrants indicate percent cells in each 
throughout, and numbers adjacent to outlined areas indicate percent Foxp3+ cells (d). (e–g) 
Analysis of Foxp3CreAtg7+/fl and Foxp3CreAtg7fl/fl mice (10–12 weeks old) under steady 
state. Total cellularity of spleen and PLNs (n=8 mice per genotype) (e). Flow cytometry 
analyzing the expression of CD62L and CD44 (f, left) and IFN-γ and IL-17 (g, left), and 
frequency of CD44hiCD62Llo cells (n=6 mice per genotype) (f, right) and IFN-γ+ or IL-17+ 
cells (n=6 mice per genotype) (g, right) in splenic Foxp3−CD4+ and CD8+ T cells. Numbers 
adjacent to outlined areas indicate percent IFN-γ+ or IL-17+ cells (g, left). (h) Hematoxylin 
and eosin staining of colon, esophagus, liver, lung, pancreas, prostate gland, salivary gland, 
and skin from Foxp3CreAtg7+/fl and Foxp3CreAtg7fl/fl mice (19–23 weeks old). 
Magnification and scale bars: ×40 and 100 μm (colon and skin), ×20 and 200 μm 
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(esophagus, liver, pancreas, prostate gland and salivary gland) and ×10 and 200 μm (lung). 
(i) Flow cytometry analyzing YFP-Foxp3 expression in CD4+ T cells (left), and frequency 
and number of YFP-Foxp3+ cells (right) in the thymus, spleen, PLNs and mesenteric lymph 
nodes (MLNs) of Foxp3CreAtg7+/fl and Foxp3CreAtg7fl/fl mice (10–12 weeks old) (n=7 mice 
per genotype). Numbers adjacent to outlined areas indicate percent YFP-Foxp3+ cells (g, 
left). NS, not significant (P > 0.05); * P < 0.05 and **P < 0.001 (two-tail unpaired Student’s 
t-test in a-c,e–g,i). Data are representative of two (a–d,h) experiments, or pooled from five 
out of six (e), four out of six (f,g) or three out of six (i) experiments (mean ± s.e.m in a–c,e–
g,i).
Wei et al. Page 17
Nat Immunol. Author manuscript; available in PMC 2016 July 25.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 2. Atg7 contributes to Treg cell survival and lineage stability
(a) Flow cytometry analyzing active caspase-3 expression (left), and frequency of 
caspase-3+ cells (right) in Treg cells from the spleen of Foxp3CreAtg7+/fl and 
Foxp3CreAtg7fl/fl mice (n=5 mice per genotype). Numbers adjacent to outlined areas 
indicate percent caspase-3+ cells (left). (b,c) Flow cytometry analyzing active caspase-3 
expression and 7-AAD staining (b) and Bim expression (c) in Treg cells (from 
Foxp3CreAtg7+/fl and Foxp3CreAtg7fl/fl mice) stimulated with anti-CD3, anti-CD28, and 
IL-2 for overnight. Numbers above bracketed lines indicate percent caspase-3+ or 7-AAD+ 
cells (b), and numbers above graph indicate mean fluorescence intensity (MFI) of Bim (c). 
(d) Flow cytometry analyzing the expression of IFN-γ and IL-17 (left), and frequency of 
IFN-γ+ cells and IL-17+ cells (right) in splenic Treg cells from Foxp3CreAtg7+/fl and 
Foxp3CreAtg7fl/fl mice (n=5 mice per genotype). Numbers in quadrants indicate percent 
cells in each throughout. (e,f) Treg cells (sorted from Foxp3CreAtg7+/fl and Foxp3CreAtg7fl/fl 
mice) were transferred into Rag1−/− mice. Flow cytometry analyzing CellTrace dilution (e, 
left) and the expression of Foxp3 (e, left) and IFN-γ and IL-17 (f, left), and frequency of 
Foxp3− cells (e, right) (n=3 mice for Atg7+/fl and n=4 mice for Atg7fl/fl) and IFN-γ+ cells 
and IL-17+ cells (f, right) (n=6 mice for Atg7+/fl and n=7 mice for Atg7fl/fl) in divided 
CellTrace-labeled donor cells (gated on CD4+TCRβ+). Numbers adjacent to outlined areas 
indicate percent CellTracelo cells (e, left), and numbers above bracketed lines indicate 
percent Foxp3− cells (e, left). (g) Flow cytometry analyzing YFP-Foxp3 expression in 
divided Treg cells (from Foxp3CreAtg7+/fl and Foxp3CreAtg7fl/fl mice) that were activated in 
vitro with anti-CD3, anti-CD28 and IL-2 for 96 h. Numbers above graphs indicate MFI of 
YFP-Foxp3. NS, not significant (P > 0.05); * P < 0.05 and ** P < 0.001 (two-tail unpaired 
Student’s t-test in a,d–f). Data are pooled from two out of five (a), four out of ten (d) or two 
out of two (f) experiments, or representative of three (b,c), ten (e) or five (g) experiments 
(mean ± s.e.m in a,d–f).
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Figure 3. Atg7 restrains TCR-dependent mTORC1 activity in Treg cells
(a) Flow cytometry analyzing cell size, and the expression of CD71, CD98 and p-S6 in 
Foxp3CreAtg7+/fl and Foxp3CreAtg7fl/fl splenic Treg cells. Numbers above graphs indicate 
MFI of FSC-A, CD71, CD98 or p-S6. (b) Immunoblot analysis of p-S6 and p-4EBP1 in 
resting, and anti-CD3 and antiCD28-stimulated Treg cells from Foxp3CreAtg7+/fl and 
Foxp3CreAtg7fl/fl mice. (c) Flow cytometry analyzing p-S6 expression in Foxp3CreAtg7+/fl 
and Foxp3CreAtg7fl/fl Treg cells stimulated with the indicated stimuli for 4 h. Numbers above 
graphs indicate MFI of p-S6. (d) Flow cytometry analyzing p-S6 expression in 
Foxp3CreAtg7+/fl and Foxp3CreAtg7fl/fl Treg cells stimulated with anti-CD3 and anti-CD28 
for 4 h in the presence of DMSO, LY294002 (10 μM), AKTi-1/2 (1 μM) or PDKi (10 μM). 
Numbers above graphs indicate MFI of p-S6. (e,f) Foxp3CreAtg7+/fl and Foxp3CreAtg7fl/fl 
mice received mock or rapamycin treatment. Treg cells were isolated and stimulated 
overnight with anti-CD3, anti-CD28, and IL-2 for analysis of caspase-3 activity (e) or 
stimulated for 4 h for analysis of IFN-γ and IL-17 expression (f). Numbers above bracketed 
lines indicate percent caspase-3+ cells (e), and numbers in quadrants indicate percent cells in 
each (f). (g) Foxp3CreAtg7+/fl or Foxp3CreAtg7fl/fl Treg cells were transferred into Rag1−/− 
mice, followed by mock (n=7 mice for Atg7+/fl and n=11 mice for Atg7fl/fl) or rapamycin 
(n=6 mice for Atg7+/fl and n=11 mice for Atg7fl/fl) treatment. Flow cytometry analyzing 
Foxp3 expression (left), and frequency of Foxp3− cells (right) in divided donor cells (gated 
on CD4+TCRβ+) in the PLNs of recipients. Numbers above bracketed lines indicate percent 
Foxp3− cells. (h) Flow cytometry analyzing YFP-Foxp3 expression in divided Treg cells 
from Foxp3CreAtg7+/fl and Foxp3CreAtg7fl/fl mice, following DMSO or rapamycin treatment 
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and activation with anti-CD3, anti-CD28, and IL-2 in vitro for 96 h. NS, not significant (P > 
0.05); * P < 0.05 (one-way ANOVA in g). Data are representative of three (a,b,d–f,h) or two 
(c) experiments, or pooled from three out of three (g) experiments (mean ± s.e.m in g).
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Figure 4. mTORC1 signaling is critical for Atg7-dependent transcriptional program
Foxp3CreAtg7+/fl and Foxp3CreAtg7fl/fl mice were treated with or without rapamycin (n=4 
mice per group). Treg cells were sorted and activated with anti-CD3 and anti-CD28 for 4 h 
for gene expression profiling. (a) Scatterplot comparing global gene-expression profiles 
between Foxp3CreAtg7+/fl and Foxp3CreAtg7fl/fl Treg cells. Transcripts with > 0.5 log2 fold 
increased (360 probes) or decreased (398 probes) expression in Foxp3CreAtg7fl/fl Treg cells 
are shown in red or blue respectively. (b,c) GSEA reveals that caspase (b) and cytokine 
pathways (c) are among the most extensively upregulated pathways in Foxp3CreAtg7fl/fl Treg 
cells as compared with Foxp3CreAtg7+/fl Treg cells. Heat maps of top hit genes in caspase (b) 
and cytokine (c) pathways. Differentially expressed genes were normalized by z-score. 
Expression levels are shown as green for low intensities, and red for high intensities. (d) 
Comparison of expression changes in rapamycin-treated Foxp3CreAtg7fl/fl versus 
Foxp3CreAtg7+/fl Treg cells with those in non-treated Foxp3CreAtg7fl/fl versus 
Foxp3CreAtg7+/fl Treg cells. The 758 Atg7 target genes (with > 0.5 log2 fold change) were 
partitioned into five main clusters, shown and colored by regions (R1–R5). Right, numbers 
indicate the number of probes within each region. (e) Heat maps of 515 rapamycin 
responsive genes that are differentially expressed in Foxp3CreAtg7fl/fl Treg cells (with > 0.5 
log2 fold change) and have diminished response after rapamycin treatment. Red color 
denotes upregulated genes in Foxp3CreAtg7fl/fl Treg cells, and blue color denotes 
downregulated genes in Foxp3CreAtg7fl/fl Treg cells. Data are from one experiment (a–e).
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Figure 5. Dysregulation of glycolytic metabolism in Atg7-deficient Treg cells contributes to 
impaired Treg cell stability
(a) Measurement of ECAR in Treg cells (from Foxp3CreAtg7+/fl and Foxp3CreAtg7fl/fl mice) 
stimulated with anti-CD3 and anti-CD28 for 4 h. (b) Ratio of OCR to ECAR of Treg cells 
(from Foxp3CreAtg7+/fl and Foxp3CreAtg7fl/fl mice) stimulated with anti-CD3 and anti-
CD28 for 4 h. (c) Measurement of ECAR in Treg cells (from Foxp3CreAtg7+/fl and 
Foxp3CreAtg7fl/fl mice) stimulated with anti-CD3 and anti-CD28 for 4 h in the presence of 
DMSO or rapamycin. (d) Flow cytometry analyzing YFP-Foxp3 expression in divided Treg 
cells (from Foxp3CreAtg7+/fl and Foxp3CreAtg7fl/fl mice) that were activated in vitro with 
anti-CD3, anti-CD28, and IL-2 for 96 h in the presence of DMSO or DCA. Numbers above 
graphs indicate MFI of YFP-Foxp3. NS, not significant (P > 0.05); * P < 0.05 and ** P < 
0.001 (two-tail unpaired Student’s t-test in a,b and one-way ANOVA in c). Data are 
representative of two (a,b), three (c) or four (d) experiments (mean ± s.e.m in a–c).
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Figure 6. Autophagy protects Treg cell stability by restraining mTORC1-dependent c-Myc 
expression and function
(a) Flow cytometry analyzing c-Myc in Treg cells (from Foxp3CreAtg7+/fl and 
Foxp3CreAtg7fl/fl mice) activated with anti-CD3 and anti-CD28 for 4 h. Numbers above 
graphs indicate MFI of c-Myc. (b) Immunoblot analysis of c-Myc in resting, and anti-CD3 
and anti-CD28 stimulated Treg cells from Foxp3CreAtg7+/fl and Foxp3CreAtg7fl/fl mice. (c,d) 
Foxp3CreAtg7+/fl and Foxp3CreAtg7fl/fl mice received mock or rapamycin treatment. Treg 
cells were isolated and stimulated with anti-CD3 and anti-CD28 for 4 h for analysis of c-
Myc expression (c). Numbers above bracketed lines indicate percent c-Myc+ cells (c). Heat 
maps of Myc target gene expression in non-treated Foxp3CreAtg7fl/fl versus 
Foxp3CreAtg7+/fl Treg cells, and rapamycin-treated Foxp3CreAtg7fl/fl versus 
Foxp3CreAtg7+/fl Treg cells (d). Red color denotes upregulated genes in Foxp3CreAtg7fl/fl 
Treg cells, and blue color denotes downregulated genes in Foxp3CreAtg7fl/fl Treg cells (d). (e) 
Measurement of ECAR in Treg cells (from Foxp3CreAtg7+/fl and Foxp3CreAtg7fl/fl mice) 
stimulated with anti-CD3 and anti-CD28 for 4 h in the presence of DMSO or JQ-1. (f) Flow 
cytometry analyzing YFP-Foxp3 expression in divided Treg cells (from Foxp3CreAtg7+/fl and 
Foxp3CreAtg7fl/fl mice) that were activated in vitro with anti-CD3 and anti-CD28, and IL-2 
for 96 h in the presence of DMSO or JQ-1. Numbers above graphs indicate MFI of YFP-
Foxp3. NS, not significant (P > 0.05); * P < 0.05 and ** P < 0.001 (one-way ANOVA in e). 
Data are representative of four (a,f), three (b,c) or two (e) experiments, or from one (d) 
experiments (mean ± s.e.m in e).
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Figure 7. Autophagy is preferentially required for activated Treg cell maintenance
(a,b) Flow cytometry analyzing the expression of YFP-Foxp3 in GFP+ and GFP− CD4+ T 
cells (a) and active caspase-3 in GFP+ and GFP− Treg cells (b) in the spleen of 
Rag2GFPFoxp3CreAtg7+/fl and Rag2GFPFoxp3CreAtg7fl/fl mice. Numbers adjacent to 
outlined areas indicate percent YFP-Foxp3+ cells (a) and caspase-3+ cells (b). (c) 
Representative images (scale bars, 5 μm) (left) and quantification of the number of GFP-
LC3+ puncta per cell (right) in cTreg and eTreg cells purified from the spleen of GFP-LC3 
mice (n=5 mice). (d,e) Flow cytometry analyzing the proportion of CD44hiCD62Llo eTreg 
cells among total Treg cells in the spleen of Foxp3CreAtg7+/fl and Foxp3CreAtg7fl/fl mice 
(n=6 mice per genotype) (d, left) and Foxp3CreAtg7+/fl and Foxp3CreAtg7fl/fl chimeras (n=4 
mice per group) (e, left), and frequency of CD44hiCD62Llo eTreg cells (d,e, right). Numbers 
adjacent to outlined areas indicate percent CD44hiCD62Llo eTreg cells (d,e, left). (f,g) Flow 
cytometry analyzing the expression of active caspase-3 (f) and p-S6 (g) in CD44loCD62Lhi 
cTreg cells and CD44hiCD62Llo eTreg cells in the spleen of Foxp3CreAtg7+/fl and 
Foxp3CreAtg7fl/fl mice. Numbers adjacent to outlined areas indicate percent caspase-3+ cells 
(f), and numbers above graphs indicate MFI of p-S6 (g). * P < 0.05 (two-tail unpaired 
Student’s t-test in c–e). Data are representative of five (a,f), three (b,g), or four (e) 
experiments, or pooled from two out of two (c) or five out of five (d) experiments (mean ± 
s.e.m in c–e).
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